Impact of Heart Failure Medications and Ventilation on Duchenne Muscular Dystrophy Survival
Heart medications and ventilation linked to longer life in DMD
A meta-analysis of over 13,000 patients reveals that home mechanical ventilation and heart failure medications significantly extend survival…
New data shows that home ventilation and specific heart medications are linked to longer lifespans for people with Duchenne muscular dystrop…
Beta-blocker therapy shows variable outcomes for myocardial infarction patients based on ejection fraction
Beta-blockers show mixed results for patients with heart conditions
This meta-analysis examined the impact of oral beta-blockers on composite outcomes including death and heart failure in patients following m…
New data shows that beta-blocker medication helps some people after a heart attack, but it may not help everyone equally.
Beta-blocker use associated with lower mortality risk in heart failure with preserved ejection fraction
Beta-Blockers Linked to Lower Mortality in Heart Failure Patients
This meta-analysis of observational studies found that beta-blocker use was associated with lower all-cause and cardiovascular mortality in …
A large study of over 400,000 patients suggests that beta-blocker use is linked to lower death rates for those with a specific type of heart…
ACEIs and Beta Blockers Show Cardioprotective Effects in Chemotherapy
ACE Inhibitors and Beta Blockers May Protect Hearts During Chemotherapy
An umbrella review of 35 meta-analyses finds ACEIs and beta blockers modestly preserve cardiac function and reduce heart failure risk during…
Specific heart medications like ACE inhibitors and beta blockers may help protect heart function in patients undergoing chemotherapy treatme…
Simplified transitional care did not improve guideline adherence in acute heart failure patients over 6 months
Simplified care plan shows no overall benefit for heart failure patients
This multicenter randomized clinical trial enrolled 982 patients with acute heart failure. The study evaluated a simplified transitional car…
A new trial found that a simplified discharge plan did not improve medication adherence or symptoms for most heart failure patients, though …
Saudi Healthcare Workers Show Divergent Knowledge And Attitudes Regarding Beta-Blocker Therapy Management Practices
Doctors and nurses in Saudi Arabia reveal hidden barriers to heart medication
A cross-sectional study of 553 Saudi healthcare providers reveals significant gaps in beta-blocker knowledge and attitudes between physician…
Fear of side effects is stopping doctors and nurses from using a key heart medication the right way, a new survey in Saudi Arabia finds.
Beta-blocker therapy in AMI patients with preserved ejection fraction shows comparable outcomes to non-use
New analysis shows beta-blockers do not lower heart attack risks for most patients with strong hearts
This meta-analysis of randomized controlled trials evaluated beta-blocker therapy in 19,826 patients with acute myocardial infarction and pr…
A large study of nearly twenty thousand patients found that taking beta-blockers after a heart attack did not reduce the risk of dying or ha…
Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction
Beta-blockers do not lower death risk for heart attack patients with strong heart pumps
This meta-analysis of 23,524 adults with myocardial infarction and left ventricular ejection fraction ≥ 40% found that beta-blockers did not…
A large review found beta-blockers did not reduce death or heart failure in adults with heart attacks and normal heart function.
24-hour diastolic BP variability linked to renal decline in diabetic kidney disease
Why Your Blood Pressure Swings Matter More Than Numbers
This retrospective cohort study of 2143 patients with diabetic kidney disease found that each 1 mmHg increase in 24-hour diastolic blood pre…
Stability matters more than the number itself when protecting kidneys.
Beta-blockers show no benefit in preserved LVEF post-MI, but may help mildly reduced LVEF
Beta-blockers may not lower heart attack risk in patients with normal heart function
This review of three randomized controlled trials and two meta-analyses found that beta-blocker therapy did not reduce death, MI, or heart f…
A review of trials suggests beta-blockers do not reduce death or heart failure in patients with preserved heart function, but may help those…
Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy
Heart-Protecting Meds Show Promise for Cancer Patients
A meta-analysis of 19 RCTs in patients receiving anthracyclines and/or trastuzumab found beta-blockers improved LVEF (WMD=2.19) and reduced…
Two specific heart medications stand out as the most effective shields against heart damage caused by powerful cancer treatments.
Remote monitoring chatbot increased GDMT target dose achievement in recently discharged HFrEF patients compared to standard care
A Simple Chatbot After Heart Failure Hospitalization May Keep You Healthier and Out of the Hospital
This randomized controlled trial enrolled 66 patients with heart failure with reduced ejection fraction (HFrEF) recently discharged from the…
For people with heart failure, consistent digital check-ins after leaving the hospital could be the key to getting the right medication stre…
All beta-blockers Articles
- Impact of Heart Failure Medications and Ventilation on Duchenne Muscular Dystrophy Survival
- Beta-blocker therapy shows variable outcomes for myocardial infarction patients based on ejection fraction
- Beta-blocker use associated with lower mortality risk in heart failure with preserved ejection fraction
- ACEIs and Beta Blockers Show Cardioprotective Effects in Chemotherapy
- Simplified transitional care did not improve guideline adherence in acute heart failure patients over 6 months
- Saudi Healthcare Workers Show Divergent Knowledge And Attitudes Regarding Beta-Blocker Therapy Management Practices
- Beta-blocker therapy in AMI patients with preserved ejection fraction shows comparable outcomes to non-use
- Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction
- 24-hour diastolic BP variability linked to renal decline in diabetic kidney disease
- Beta-blockers show no benefit in preserved LVEF post-MI, but may help mildly reduced LVEF
- Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy
- Remote monitoring chatbot increased GDMT target dose achievement in recently discharged HFrEF patients compared to standard care
- Beta-blocker discontinuation noninferior to continuation in stable post-MI patients without heart failure